Medical Doctor Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Soma Wali

Internal Medicine Sylmar, CA Medical Doctor

NPI 1497833420 CMS profile 1061409

14445 Olive View Dr, Department Of Medicine, Room 2B182, Sylmar, CA 91342

Open in the dashboard

General payments

$36,963

16 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Soma Wali of Sylmar, CA is reported in the CMS Open Payments database as having received $36,963 across 16 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Internal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $10,590 5
2024 General $9,719 6
2023 General $16,654 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Soma Wali
  • Internal Medicine median
  • Middle half of Internal Medicine
  • National median

In program year 2025, general payments to Soma Wali were reported at $10,590. Among 52,115 Internal Medicine profiles paid that year, the median was $156 and the middle half received between $47 and $551.

Show as a table
Year Soma Wali Internal Medicine median Middle half National median
2019 $0 $159 $48–$570 $163
2020 $0 $119 $33–$402 $114
2021 $0 $135 $37–$521 $132
2022 $0 $141 $42–$496 $149
2023 $16,654 $149 $45–$519 $160
2024 $9,719 $154 $47–$537 $164
2025 $10,590 $156 $47–$551 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. Novo Nordisk Inc $36,963 16 payments

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Consulting Fee $31,500 5 payments
  2. Travel and Lodging $3,628 8 payments
  3. Food and Beverage $1,835 3 payments

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

216

Median for Internal Medicine: 777

Drug cost

$2,997

Median for Internal Medicine: $73,373

Branded share of claims

31.9%

Median for Internal Medicine: 19.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Paxlovid Nirmatrelvir/Ritonavir Brand 17 $1,351
Fluticasone Propionate Generic 71 $721
Albuterol Sulfate Hfa Albuterol Sulfate Brand 17 $319
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 24 $208
Cephalexin Generic 28 $155
Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst Brand 11 $140
Triamcinolone Acetonide Generic 12 $48
Azithromycin Generic 24 $47
Prednisone Generic 12 $8

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 104,182 Part D prescribers listed as Internal Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 28 billing codes

Paid by Medicare

$24,671

Of which drugs: $327

Medicare patients

276

Average age 74

Services billed

409

166 women, 110 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 71%
Arthritis 58%
Ischemic heart disease 38%
Diabetes 33%
Depression 30%
Cancer 22%
Osteoporosis 22%
Chronic kidney disease 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

16 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Internal Medicine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record